Search Within

Parisa Momtaz

  1. "Body Imaging Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (7)
  2. Body Imaging Service (7)
  3. Department of Medicine (7)
  4. Epidemiology and Biostatistics (7)
  5. Melanoma Disease Management Team (7)
  6. Melanoma and Immunotherapeutics Service (7)

More Groups

People
  1. Elizabeth Won (5)
  2. David Ilson (4)
  3. David Kelsen (4)
  4. David Solit (4)
  5. Geoffrey Ku (4)
  6. Jaclyn Hechtman (4)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2020 (1)
  4. 2019 (3)
Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Oncology (1)
  3. Lancet Oncology (1)
  4. Nature (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Science, Inc. (1)
  3. Nature Publishing Group (1)
  4. Oxford University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Colorectal cohort analysis from the intraperitoneal chemotherapy after cytoreductive surgery for peritoneal metastasis (ICARuS) clinical trial
    Meeting Abstract

    Nash, G. M.; Garcia-Aguilar, J.; Paty, P.; Gonen, M.; Foote, M. B.; Chung, S.; Mohamed, M.; Aguirre, N.; Weiser, M. R.; Rassam, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save